Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Can Machine Learning Models Predict Asparaginase-associated Pancreatitis in Childhood Acute Lymphoblastic Leukemia

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Abdominal Complications During Treatment for Pediatric Acute Myeloid Leukemia

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Meropenem to Children With Febrile Neutropenia Induces Monoresistant Pseudomonas aeruginosa

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Improved Survival of Children, Adolescents, and Young Adults With Head and Neck Soft Tissue Sarcomas in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Hearing Status in Survivors of Childhood Acute Myeloid Leukemia Treated With Chemotherapy Only: A NOPHO-AML Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Changes in body mass index during treatment of childhood acute lymphoblastic leukemia with the Nordic ALL2008 protocol

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. End-of-life communication: a nationwide study of bereaved parents' perceptions

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. EXABS-103-ALL Advances in ALL Diagnosis and Treatment -The NOPHO Experience

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Cancer-related Mutations with Local or Long-range Effects on an Allosteric Loop of p53

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Rikke L Nielsen
  • Benjamin O Wolthers
  • Marianne Helenius
  • Birgitte K Albertsen
  • Line Clemmensen
  • Kasper Nielsen
  • Jukka Kanerva
  • Riitta Niinimäki
  • Thomas L Frandsen
  • Andishe Attarbaschi
  • Shlomit Barzilai
  • Antonella Colombini
  • Gabriele Escherich
  • Derya Aytan-Aktug
  • Hsi-Che Liu
  • Anja Möricke
  • Sujith Samarasinghe
  • Inge M van der Sluis
  • Martin Stanulla
  • Morten Tulstrup
  • Rachita Yadav
  • Ester Zapotocka
  • Kjeld Schmiegelow
  • Ramneek Gupta
View graph of relations

Asparaginase-associated pancreatitis (AAP) frequently affects children treated for acute lymphoblastic leukemia (ALL) causing severe acute and persisting complications. Known risk factors such as asparaginase dosing, older age and single nucleotide polymorphisms (SNPs) have insufficient odds ratios to allow personalized asparaginase therapy. In this study, we explored machine learning strategies for prediction of individual AAP risk. We integrated information on age, sex, and SNPs based on Illumina Omni2.5exome-8 arrays of patients with childhood ALL (N=1564, 244 with AAP 1.0 to 17.9 yo) from 10 international ALL consortia into machine learning models including regression, random forest, AdaBoost and artificial neural networks. A model with only age and sex had area under the receiver operating characteristic curve (ROC-AUC) of 0.62. Inclusion of 6 pancreatitis candidate gene SNPs or 4 validated pancreatitis SNPs boosted ROC-AUC somewhat (0.67) while 30 SNPs, identified through our AAP genome-wide association study cohort, boosted performance (0.80). Most predictive features included rs10273639 (PRSS1-PRSS2), rs10436957 (CTRC), rs13228878 (PRSS1/PRSS2), rs1505495 (GALNTL6), rs4655107 (EPHB2) and age (1 to 7 y). Second AAP following asparaginase re-exposure was predicted with ROC-AUC: 0.65. The machine learning models assist individual-level risk assessment of AAP for future prevention trials, and may legitimize asparaginase re-exposure when AAP risk is predicted to be low.

Original languageEnglish
Article number0000000000002292
JournalJournal of Pediatric Hematology/Oncology
Volume44
Issue number3
Pages (from-to)e628-e636
Number of pages9
ISSN1077-4114
DOIs
Publication statusPublished - 1 Apr 2022

Bibliographical note

Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc.

    Research areas

  • Antineoplastic Agents/adverse effects, Asparaginase/adverse effects, Child, Genome-Wide Association Study, Humans, Machine Learning, Pancreatitis/chemically induced, Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy, pediatric hematology/oncology, artificial intelligence, acute lymphoblastic leukemia, translational research, treatment toxicity

ID: 78116656